Turnover and proliferation of NK cells in steady state and lymphopenic conditions

被引:128
作者
Jamieson, AM
Isnard, P
Dorfman, JR
Coles, MC
Raulet, DH
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA
关键词
D O I
10.4049/jimmunol.172.2.864
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To gain insight into NK cell dynamics, we investigated the turnover and proliferation rates of NK cells in normal and lymphopenic conditions. In contrast to previous reports suggesting a very rapid turnover of NK cells, continuous 5-bromo-2'-deoxyuridine (BrdU)-labeling studies demonstrated that the time necessary for labeling 50% of splenic NK cells in mature mice was 17 days, similar to the rate of labeling of memory T cells. In contrast, in young mice, splenic NK cells labeled very rapidly with BrdU, although cell cycle analyses and BrdU pulse-labeling studies suggested that most of this proliferation occurred in a precursor population. A somewhat larger percentage of bone marrow NK cells was cycling, suggesting that these proliferating cells are the precursors of the mostly nondividing or slowly dividing splenic NK cells. Splenic NK cells from mature mice also did not proliferate significantly when transferred to normal mice, but did proliferate when transferred to irradiated mice. Thus, NK cells, like T cells, undergo homeostatic proliferation in a lymphopenic environment. Homeostatic proliferation of NK cells was not dependent on host cell class I molecules or host production of IL-15. Nevertheless, the number of recovered NK cells was much lower in IL-15(-/-) hosts. These results suggest that IL-15 is not essential for homeostatic proliferation of NK cells, but is necessary for survival of the NK cells. Our results provide important basic information concerning the production and replacement of NK cells. The Journal of Immunology, 2004, 172: 864-870.
引用
收藏
页码:864 / 870
页数:7
相关论文
共 47 条
  • [1] Natural killer cells in antiviral defense: Function and regulation by innate cytokines
    Biron, CA
    Nguyen, KB
    Pien, GC
    Cousens, LP
    Salazar-Mather, TP
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 189 - 220
  • [2] BIRON CA, 1982, J IMMUNOL, V129, P2788
  • [3] Potential role for interleukin-15 in the regulation of human natural killer cell survival
    Carson, WE
    Fehniger, TA
    Haldar, S
    Eckhert, K
    Lindemann, MJ
    Lai, CF
    Croce, CM
    Baumann, H
    Caligiuri, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) : 937 - 943
  • [4] In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells
    Cooper, MA
    Bush, JE
    Fehniger, TA
    VanDeusen, JB
    Waite, RE
    Liu, Y
    Aguila, HL
    Caligiuri, MA
    [J]. BLOOD, 2002, 100 (10) : 3633 - 3638
  • [5] The innate immune response to tumors and its role in the induction of T-cell immunity
    Diefenbach, A
    Raulet, DH
    [J]. IMMUNOLOGICAL REVIEWS, 2002, 188 : 9 - 21
  • [6] Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
    Diefenbach, A
    Jensen, ER
    Jamieson, AM
    Raulet, DH
    [J]. NATURE, 2001, 413 (6852) : 165 - 171
  • [7] LYMPHOID DEVELOPMENT IN MICE WITH A TARGETED DELETION OF THE INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN
    DISANTO, JP
    MULLER, W
    GUYGRAND, D
    FISCHER, A
    RAJEWSKY, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) : 377 - 381
  • [8] KINETICS OF MATURE T-CELL DEVELOPMENT IN THE THYMUS
    EGERTON, M
    SCOLLAY, R
    SHORTMAN, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) : 2579 - 2582
  • [9] The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery
    Ernst, B
    Lee, DS
    Chang, JM
    Sprent, J
    Surh, CD
    [J]. IMMUNITY, 1999, 11 (02) : 173 - 181
  • [10] IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: The potential role of NK cell subpopulations
    Evans, R
    Fuller, JA
    Christianson, G
    Krupke, DM
    Troutt, AB
    [J]. CELLULAR IMMUNOLOGY, 1997, 179 (01) : 66 - 73